GlassScriptPrepare for your visit
Michael M Hux
Medical · Clearwater, FL · NPI 1902863277
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,215.82
in general payments reported to CMS, 2019-2025 · $1,542 in 2025
The $1,542 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Who reported paying
General payments only, top 6 by amount.
- Boston Scientific Corporation $1,520.21
- Collegium Pharmaceutical, INC. $545.88
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $450.92
- Medtronic, INC. $389.74
- Abbott Laboratories $373.34
- Tersera Therapeutics LLC $332.54
Drugs and devices associated with these payments
Wavewriter Alpha Prime 16 Proclaim Xtampza Xifaxan Senza Prialt Rezdiffra Trulance Plenvu Intellis Adaptivestim Evoke Rexulti
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Hux listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11226301/michael-m-hux